• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

蛋白激酶C-ζ的活性而非水平在阿尔茨海默病微血管中降低。

Protein kinase C-zeta activity but not level is decreased in Alzheimer's disease microvessels.

作者信息

Moore P, White J, Christiansen V, Grammas P

机构信息

Department of Pathology, University of Oklahoma Health Sciences Center, Oklahoma City 73104, USA.

出版信息

Neurosci Lett. 1998 Sep 18;254(1):29-32. doi: 10.1016/s0304-3940(98)00653-3.

DOI:10.1016/s0304-3940(98)00653-3
PMID:9780084
Abstract

While there is considerable evidence demonstrating altered activity of the major isoforms of protein kinase C (PKC) in the vasculature and neurons of Alzheimer disease (AD) brains, little is known about the activity and/or levels of the atypical PKC isoforms. The objective of this study is to compare PKC-zeta activity and level in cerebral microvessels isolated from AD brains with microvessels from the brains of nondemented age-matched controls. Measurements of the kinase activity reveals that the PKC-zeta activity is significantly (P < 0.01) lower in AD brain microvessels compared with vessels from control brain. Despite this decrease in enzyme activity, the level of PKC-zeta, assessed by Western blot, is significantly (P < 0.01) elevated in AD microvessels. These data demonstrate significant and divergent changes in the PKC-zeta activity and level in the microcirculation of the AD brain and suggest that aberrant regulation of microvascular PKC-zeta could contribute to the abnormal signaling mechanisms at the blood-brain barrier in the AD brain.

摘要

虽然有大量证据表明,阿尔茨海默病(AD)患者大脑的血管和神经元中蛋白激酶C(PKC)的主要亚型活性发生了改变,但对于非典型PKC亚型的活性和/或水平却知之甚少。本研究的目的是比较从AD患者大脑中分离出的脑微血管中PKC-ζ的活性和水平与年龄匹配的非痴呆对照者大脑微血管中的情况。激酶活性测量结果显示,与对照者大脑中的血管相比,AD患者脑微血管中的PKC-ζ活性显著降低(P < 0.01)。尽管酶活性有所下降,但通过蛋白质印迹法评估,AD患者微血管中PKC-ζ的水平却显著升高(P < 0.01)。这些数据表明,AD患者大脑微循环中PKC-ζ的活性和水平发生了显著且不同的变化,并提示微血管PKC-ζ的异常调节可能导致AD患者血脑屏障处的信号转导机制异常。

相似文献

1
Protein kinase C-zeta activity but not level is decreased in Alzheimer's disease microvessels.蛋白激酶C-ζ的活性而非水平在阿尔茨海默病微血管中降低。
Neurosci Lett. 1998 Sep 18;254(1):29-32. doi: 10.1016/s0304-3940(98)00653-3.
2
Cerebral microvessels in Alzheimer's have reduced protein kinase C activity.阿尔茨海默病患者的脑微血管中蛋白激酶C活性降低。
Neurobiol Aging. 1995 Jul-Aug;16(4):563-9. doi: 10.1016/0197-4580(95)00048-j.
3
Effects of chronic lithium treatment on platelet PKC isozymes in Alzheimer's and elderly control subjects.慢性锂治疗对阿尔茨海默病患者和老年对照受试者血小板蛋白激酶C同工酶的影响。
Neurosci Lett. 1993 Nov 12;162(1-2):187-91. doi: 10.1016/0304-3940(93)90592-9.
4
Ca2+-dependent and Ca2+-independent protein kinase C changes in the brain of patients with Alzheimer's disease.阿尔茨海默病患者大脑中钙依赖和非钙依赖的蛋白激酶C变化。
J Neurochem. 1996 Jul;67(1):317-23. doi: 10.1046/j.1471-4159.1996.67010317.x.
5
Characterization and differential distribution of the three major human protein kinase C isozymes (PKC alpha, PKC beta, and PKC gamma) of the central nervous system in normal and Alzheimer's disease brains.正常和阿尔茨海默病大脑中枢神经系统中三种主要人类蛋白激酶C同工酶(PKCα、PKCβ和PKCγ)的特性及差异分布
Lab Invest. 1991 Jan;64(1):35-44.
6
Platelet protein kinase C levels in Alzheimer's disease.阿尔茨海默病中的血小板蛋白激酶C水平
Neurobiol Aging. 1994 Nov-Dec;15(6):671-4. doi: 10.1016/0197-4580(94)90047-7.
7
Expression and phosphorylation of protein kinase C isoforms in Abeta(1-42) activated T lymphocytes from Alzheimers disease.阿尔茨海默病中β淀粉样蛋白(1-42)激活的T淋巴细胞中蛋白激酶C亚型的表达与磷酸化
Int J Immunopathol Pharmacol. 2008 Jan-Mar;21(1):23-33. doi: 10.1177/039463200802100104.
8
Differential involvement of protein kinase C isozymes in Alzheimer's disease.蛋白激酶C同工酶在阿尔茨海默病中的不同参与情况。
J Neurosci. 1990 Jul;10(7):2113-24. doi: 10.1523/JNEUROSCI.10-07-02113.1990.
9
Assessment of protein kinase C isozymes by two-site enzyme immunoassay in human brains and changes in Alzheimer's disease.通过双位点酶免疫测定法评估人脑中的蛋白激酶C同工酶以及阿尔茨海默病中的变化。
Neurology. 1993 Jul;43(7):1407-13. doi: 10.1212/wnl.43.7.1407.
10
Nitric oxide synthase activity is elevated in brain microvessels in Alzheimer's disease.一氧化氮合酶活性在阿尔茨海默病患者的脑微血管中升高。
Biochem Biophys Res Commun. 1994 Nov 30;205(1):659-65. doi: 10.1006/bbrc.1994.2716.

引用本文的文献

1
Viable human brain microvessels for the study of aging and neurodegenerative diseases.可用于研究衰老和神经退行性疾病的人类大脑微血管。
Microvasc Res. 2022 Mar;140:104282. doi: 10.1016/j.mvr.2021.104282. Epub 2021 Nov 20.
2
Dysregulated expression of monoacylglycerol lipase is a marker for anti-diabetic drug metformin-targeted therapy to correct impaired neurogenesis and spatial memory in Alzheimer's disease.单酰甘油脂肪酶表达失调是抗糖尿病药物二甲双胍靶向治疗的标志物,可纠正阿尔茨海默病中受损的神经发生和空间记忆。
Theranostics. 2020 May 15;10(14):6337-6360. doi: 10.7150/thno.44962. eCollection 2020.
3
Attenuation of amyloid-β generation by atypical protein kinase C-mediated phosphorylation of engulfment adaptor PTB domain containing 1 threonine 35.
非典型蛋白激酶 C 介导的吞噬衔接蛋白含有 PTB 结构域 1 第 35 位苏氨酸磷酸化对淀粉样β生成的抑制作用。
FASEB J. 2019 Nov;33(11):12019-12035. doi: 10.1096/fj.201802825RR. Epub 2019 Aug 5.
4
Common mechanisms of Alzheimer's disease and ischemic stroke: the role of protein kinase C in the progression of age-related neurodegeneration.阿尔茨海默病与缺血性中风的共同机制:蛋白激酶C在年龄相关性神经退行性变进展中的作用
J Alzheimers Dis. 2015;43(3):711-24. doi: 10.3233/JAD-141422.
5
Neurotoxicology of the brain barrier system: new implications.脑屏障系统的神经毒理学:新的启示
J Toxicol Clin Toxicol. 2001;39(7):711-9. doi: 10.1081/clt-100108512.